| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/17/2013 | US8536149 TRPM-2 antisense therapy |
| 09/17/2013 | US8536137 Methods for treating nucleoside-induced pain |
| 09/17/2013 | US8536136 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/17/2013 | US8536135 Adaptive biochemical signatures |
| 09/17/2013 | US8536134 Mixture of Cyclosporin A, oil and surfactant |
| 09/17/2013 | US8536133 Selective high-affinity polydentate ligands and methods of making such |
| 09/17/2013 | US8536132 Lymphatic zip codes in tumors and pre-malignant lesions |
| 09/17/2013 | US8536131 Synthetic peptide amides and dimers thereof |
| 09/17/2013 | US8536130 Use of 1 phenyl-3-dimethylamino-propane compounds for treating neuropathic pain |
| 09/17/2013 | US8536129 Treatment for anxiety |
| 09/17/2013 | US8536128 Granulin/epithelin precursor (GEP), a chondrogenic growth factor and target in cartilage disorders |
| 09/17/2013 | US8536127 Protein stabilization in solution |
| 09/17/2013 | US8536126 Conjugated factor VIII molecules |
| 09/17/2013 | US8536125 Stabilization of liquid solutions of recombinant protein for frozen storage |
| 09/17/2013 | US8536124 Artificial decapeptide for inducing vitellogenesis in fish |
| 09/17/2013 | US8536123 Use of blood flow parameters to monitor or control the dosing of erythropoiesis-stimulating agents |
| 09/17/2013 | US8536122 Acylated GLP-1 compounds |
| 09/17/2013 | US8536121 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance using beta-arrestin2 and its up-regulators |
| 09/17/2013 | US8536120 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
| 09/17/2013 | US8536117 Oxidant resistant apolipoprotein A-1 and mimetic peptides |
| 09/17/2013 | US8536116 Antagonists for diseases induced by cells with high-affinity ELR-CXC chemokine receptor proteins |
| 09/17/2013 | US8536115 Compositions and methods for modulating AMPA receptor-mediated excitotoxicity |
| 09/17/2013 | US8536114 Macrocycles |
| 09/17/2013 | US8535912 Chimeric fibroblast growth factors with altered receptor specificity |
| 09/17/2013 | US8535904 Method of enhancing skin barrier function |
| 09/17/2013 | US8535899 Assay for identifying a modulator of HIF hydroxylase |
| 09/17/2013 | US8535898 Thrombin substrate and assay for determining the level of bioactive thrombin in a sample |
| 09/17/2013 | US8535885 Detection of disease related genes |
| 09/17/2013 | US8535716 Methods and composition of extended delivery of water insoluble drugs |
| 09/17/2013 | US8535715 Bilayer tablet formulations |
| 09/17/2013 | US8535701 Sustained delivery of an active agent using an implantable system |
| 09/17/2013 | US8535690 Tumor specific animal proteins |
| 09/17/2013 | US8535681 Sustained drug delivery system |
| 09/17/2013 | US8535680 Anti-LPS factor from Parietaria judaica and methods of use thereof |
| 09/17/2013 | US8535673 A humanized antibody that specifically binds an epitope contained within positions 13-28 of A beta; used for treating Alzheimer's disease in both asymptomatic patients and those currently showing symptoms of disease. |
| 09/17/2013 | US8535670 Method of treating colorectal cancer tumor |
| 09/17/2013 | US8535663 Method for treating delayed-type hypersensitivity |
| 09/17/2013 | US8535662 Apyrase therapy for bleeding conditions |
| 09/17/2013 | US8535661 Enzymatically active compositions for suppressing sulfide generation and methods of use thereof |
| 09/17/2013 | US8535660 Nutritional supplements for pregnant women |
| 09/17/2013 | US8535659 Nutritional supplements for pregnant women |
| 09/17/2013 | US8535657 Stabilized pharmaceutical formulations that contain the interferons gammas and alpha in synergistic proportions |
| 09/17/2013 | US8535258 Hemofiltration methods for treatment of diseases in a mammal |
| 09/17/2013 | CA2693382C Fused stem cells useful for the treatment of diabetes and methods thereof |
| 09/17/2013 | CA2690773C Pharmaceutical liquid composition of botulinum toxin with improved stability |
| 09/17/2013 | CA2645701C Process for obtaining a concentrate of von willebrand factor or a complex of factor viii/von willebrand factor and use of the same |
| 09/17/2013 | CA2554486C Treatment of bacterial infections |
| 09/17/2013 | CA2546794C Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 09/17/2013 | CA2534748C Relaxin superfamily peptide analogues |
| 09/17/2013 | CA2533789C Epha2 t-cell epitope agonists and uses therefor |
| 09/17/2013 | CA2451738C Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine |
| 09/17/2013 | CA2423093C Improved system for regulation of transgene expression |
| 09/17/2013 | CA2348382C Chimeric parvovirus vectors and methods of making and administering the same |
| 09/17/2013 | CA2347067C Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer |
| 09/17/2013 | CA2285701C .beta.-catenin, tcf-4, and apc interact to prevent cancer |
| 09/12/2013 | WO2013134736A1 Compositions, methods, and kits for regulating energy metabolism |
| 09/12/2013 | WO2013134666A1 Use of thymosin alpha for treatment of purulent rhinosinusitis |
| 09/12/2013 | WO2013134636A1 Compositions and methods for delivery of kinase inhibiting peptides |
| 09/12/2013 | WO2013134464A1 Tissue constructs and uses thereof |
| 09/12/2013 | WO2013134293A1 Vaccine formulation |
| 09/12/2013 | WO2013134273A1 Methods for modulation of phosphorus and fgf23 |
| 09/12/2013 | WO2013134249A1 Adipose tissue targeted peptides |
| 09/12/2013 | WO2013134177A1 Methods and compositions for improving spinal surgery outcomes |
| 09/12/2013 | WO2013134138A1 Engineered antibody-interferon mutant fusion molecules |
| 09/12/2013 | WO2013134116A1 Hsp90 inhibitor for the treatment of cancer and inflammatory diseases |
| 09/12/2013 | WO2013134030A1 Novel cellular targets for hiv infection |
| 09/12/2013 | WO2013133667A1 Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease |
| 09/12/2013 | WO2013133413A1 Mucosa-elevating agent |
| 09/12/2013 | WO2013133327A1 Bone-strengthening agent |
| 09/12/2013 | WO2013133326A1 Bone-strengthening agent |
| 09/12/2013 | WO2013133032A1 Dipeptidyl peptidase-iv inhibitor |
| 09/12/2013 | WO2013133031A1 Dipeptidyl peptidase-iv inhibitor |
| 09/12/2013 | WO2013132675A1 Bone-strengthening agent |
| 09/12/2013 | WO2013132670A1 Semi-solidified nutritive agent |
| 09/12/2013 | WO2013132668A1 Composition comprising imidazole peptide and quercetin glycoside |
| 09/12/2013 | WO2013132485A1 Polymers having therapeutically active agents conjugated thereto, processes of preparing same and uses thereof |
| 09/12/2013 | WO2013132428A1 Therapeutic preparation and process for preparing said therapeutic preparation |
| 09/12/2013 | WO2013132272A1 Erythropoiesis |
| 09/12/2013 | WO2013132267A1 Treatment of cancer |
| 09/12/2013 | WO2013132054A1 Prevention of infection |
| 09/12/2013 | WO2013131879A1 New application for pasireotide |
| 09/12/2013 | WO2013106766A3 THERAPEUTIC INDICATIONS OF miR-1291 |
| 09/12/2013 | WO2012098537A8 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells |
| 09/12/2013 | WO2012083259A3 Method, system and apparatus for control of pancreatic beta cell function to improve glucose homeostatis and insulin production |
| 09/12/2013 | US20130239234 Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain |
| 09/12/2013 | US20130237961 Intradermal delivery of substances |
| 09/12/2013 | US20130237960 Intradermal delivery of substances |
| 09/12/2013 | US20130237586 DELIVERY OF dsRNA TO ARTHROPODS |
| 09/12/2013 | US20130237485 Methods and Agents for Enhancing Wound Healing |
| 09/12/2013 | US20130237482 Medicament for therapeutic treatment and/or improvement of sepsis |
| 09/12/2013 | US20130237480 Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes |
| 09/12/2013 | US20130237479 Composition for controlled ovarian stimulation |
| 09/12/2013 | US20130237478 Compositions and methods for treatment of peripheral vascular disease |
| 09/12/2013 | US20130237477 Compositions and methods for increasing vascularization |
| 09/12/2013 | US20130237451 Compositions and methods for treatment of protein misfolding diseases |
| 09/12/2013 | US20130236889 Vascularization Inhibitors |
| 09/12/2013 | US20130236553 Compositions and Methods for the Delivery of Therapeutics |
| 09/12/2013 | US20130236550 Pharmaceutical microparticles |
| 09/12/2013 | US20130236513 Synthetic Polyurethane Composite |
| 09/12/2013 | US20130236509 Microparticles comprising a small heat-shock protein |